Latest News & Features
Big Pharma
The market for counterfeit pharmaceuticals is worth $200 billion a year, beating almost everything else in the underground economy, including prostitution, human trafficking and illegal arms sales. 28 November 2016
Big Pharma
The English High Court has ruled in favour of Merck Sharp & Dohme (MSD) in a patent battle against Shionogi, over Merck’s product Isentress. 28 November 2016
Americas
AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling. 25 November 2016
Americas
Novartis has acquired Selexys Pharmaceuticals Corporation, a company specialising in the development of therapeutics in certain hematologic and inflammatory disorders. 25 November 2016
Americas
A California district court has dismissed a lawsuit filed by The Scripps Research Institute, a US non-profit medical research facility, against biotechnology company Illumina for alleged patent infringement. 24 November 2016
Asia
India-based drugs company Sun Pharma has agreed to acquire Russia-based pharmaceutical business Biosintez. 24 November 2016
Europe
Intellectual property in the life sciences arena can be an attractive investment target, but a long process of evaluation must take place first, cautions Dimitar Georgiev, founder and CEO of Paralax Life Sciences. 24 November 2016
Africa
Benin yesterday accepted the 2005 protocol amending the World Trade Organization’s (WTO) agreement on TRIPS, a protocol intended to ease poorer WTO members’ access to affordable medicines. 24 November 2016
Americas
The International Trademark Association (INTA) has filed an amicus brief asking the US Supreme Court to review a decision in a case between Belmora and Bayer centring on pain relief drug Flanax. 23 November 2016
Americas
California’s biopharmaceutical and medical device employment rate grew by 7% between 2011 and 2015, a recent report by the California Life Sciences Association (CLSA) and PwC US has revealed. 23 November 2016